NoeticInsight

NoeticInsight Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from NoeticInsight, Medical and health, 1 Cattano Avenue, Morristown, NJ.

🗨️FDA to lower the number of trails trials required for approval of drugs What will it mean for the FDA to lower the num...
01/29/2026

🗨️FDA to lower the number of trails trials required for approval of drugs What will it mean for the FDA to lower the number of trials necessary for drug approval? The move may not be that surprising, given that drugmakers already submit only one pivotal trial for approval.

🔎Looking for an expert’s insight into the latest news in pharma and the life sciences? NoeticInsight provides tailored insights, in real-time, from your global clinical experts. See how at https://hubs.li/Q0409b670


Source: https://hubs.li/Q0409f_q0

⚕️Anito-cel is an experimental CAR T cell therapy for relapsed/refractory multiple myeloma patients that demonstrated 97...
01/27/2026

⚕️Anito-cel is an experimental CAR T cell therapy for relapsed/refractory multiple myeloma patients that demonstrated 97% overall response rate and 68% complete response rate. The therapy will undergo Phase 3 study to compare against the current standard of care.

📌Interested in how this trial data is shaping the market? Talk to an expert rapidly through a secure platform with NoeticInsight: https://hubs.li/Q0408T0j0


Source: https://hubs.li/Q0408SKV0

📌At ASH, GSK oncology executive Hesham Abdullah discussed the restricted approval of Blenrep in the US compared to other...
01/23/2026

📌At ASH, GSK oncology executive Hesham Abdullah discussed the restricted approval of Blenrep in the US compared to other countries, citing the FDA’s view on the benefit-risk profile of the drug and the updates since made to the REMS program.

👉Interested in exploring more about multiple myeloma treatments? Our experts are ready to discuss and provide their insights. Get started at https://hubs.li/Q03-_RRD0



Source: https://hubs.li/Q03-_RVp0
multiple-myeloma-adc-fda-ash/

🌺Registration is OPEN for PRIMO 2026April 8-11, 2026Ritz Carlton MauiKapalua, HI Don’t miss out on our renowned annual m...
01/21/2026

🌺Registration is OPEN for PRIMO 2026

April 8-11, 2026
Ritz Carlton Maui
Kapalua, HI Don’t miss out on our renowned annual meeting! Registration for PRIMO 2026 is open at https://hubs.li/Q03-_GJ70

📌At PRIMO, you can expect updates on targeted therapies, immunotherapy, and next-generation sequencing; guidance on biomarker testing, treatment sequencing, and patient selection; expert-led sessions and interactive panels; and strategies for managing treatment-related toxicities and improving patient outcomes.

✨As a sponsor, you’ll support the practical applications of the latest in cancer research on immuno and molecular therap...
01/09/2026

✨As a sponsor, you’ll support the practical applications of the latest in cancer research on immuno and molecular therapies, all while gaining access to a highly select audience.

🚨Mark your calendars for our upcoming summits:

o February 28, San Francisco: GU Cancers
o March 6-7, Los Angeles: Hematology (Multiple Myeloma)
o March 20-21, Miami: Lung Cancer

👉Learn more about sponsorship at: https://hubs.li/Q03ZXQFp0

📃A study published in AACR analyzed major modifiable cancer risk factors in the years before and after the COVID-19 pand...
01/05/2026

📃A study published in AACR analyzed major modifiable cancer risk factors in the years before and after the COVID-19 pandemic. Factors studied included aerobic exercise, body weight, smoking habits, screenings, and HPV vaccination. While some factors remained stable, others changed. These insights will help develop effective cancer prevention and control efforts.

🚨Interested in exploring the details of this study with an expert, or multiple experts? See how you can get connected with NoeticInsight: https://hubs.li/Q03YxqKv0


Source: https://hubs.li/Q03YxkWZ0

👉As a PRIMO Meeting or Summits sponsor, you can support learning and development for oncology practitioners and help the...
01/02/2026

👉As a PRIMO Meeting or Summits sponsor, you can support learning and development for oncology practitioners and help them understand how and when to integrate immuno and molecular therapies into their practices.

🫁Learn more about sponsoring our upcoming lung cancer summit or one of our many other programs! https://hubs.li/Q03XWYRV0

💉Cancer vaccines hold much promise for oncology, but require further research and refinement are needed to amplify their...
12/30/2025

💉Cancer vaccines hold much promise for oncology, but require further research and refinement are needed to amplify their effectiveness. Cancer vaccines are unique in that they can help patients who are resistant to other therapies with the ability to initiate broad and durable T cell responses.

📌Interested in speaking with an expert about cancer vaccines? See how NoeticInsight can help: https://hubs.li/Q03YxbJ60


Source: https://hubs.li/Q03YxcCz0

📄The AACR Cancer Progress Report 2025 highlights significant advances that have defined cancer care and prevention in th...
12/16/2025

📄The AACR Cancer Progress Report 2025 highlights significant advances that have defined cancer care and prevention in the last year. While there is always more work to be done, and continued support needed for research, progress thus far has helped patients live longer lives after a cancer diagnosis.

📌When you need a rapid way to connect with cancer experts, consider NoeticInsight: https://hubs.li/Q03XWCMy0



Source: https://hubs.li/Q03XWBPV0

🌟We are eagerly anticipating the largest breast cancer research meeting in the world!Conferences are fantastic opportuni...
12/09/2025

🌟We are eagerly anticipating the largest breast cancer research meeting in the world!

Conferences are fantastic opportunities to hear the latest research in cancer. When you need to turn the wealth of knowledge into practical applications and useful summaries, turn to NoeticInsight: https://hubs.li/Q03XmWTp0

💡There will be 5000+ abstracts at ASH 2025, and we’ll be gathering insights to help inform how clinical practice will be...
12/08/2025

💡There will be 5000+ abstracts at ASH 2025, and we’ll be gathering insights to help inform how clinical practice will be affected.

If you’re looking to make the most of your congress experiences, learn more about Noetic Insight: https://hubs.li/Q03XmWb50

📈The ongoing phase 3 trial, RadComp, shows similar health-related quality of life for proton radiotherapy compared to ph...
12/03/2025

📈The ongoing phase 3 trial, RadComp, shows similar health-related quality of life for proton radiotherapy compared to photon radiotherapy. If the results remain consistent as the trial progresses over the next few years, proton therapy may potentially offer patients a treatment with minimal exposure to tissues beyond the tumor and may reduce radiation-associated morbidity.

⚕️To track developments in clinical trial results like RadComp, connect with NoeticInsight: https://hubs.li/Q03TVyKc0



Source: https://hubs.li/Q03TVG2J0

Address

1 Cattano Avenue
Morristown, NJ
07960

Website

Alerts

Be the first to know and let us send you an email when NoeticInsight posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram